Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study2015 · 21 citations
2. 2Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity2016 · 116 citations
3. 3Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity2014 · 150 citations
4. 4Impact of Sativex ^® on quality of life and activities of daily living in patients with multiple sclerosis spasticity2014 · 23 citations
5. 5Observational Safety Study of THC: CBD Oromucosal Spray (Sativex) in Multiple Sclerosis Patients with Spasticity2015 · 27 citations